Brock et al. [32] suggest that the lowering of the systematic levels of proinflammatory cytokines observed, in particular interleukin-6 levels (p = 0.025), may lead to prevention of the neuroinflammatory component in early stages of diabetes neuropathy. Here, IL6 is linked to diabetes mellitus.